Clozapine‐induced third‐degree atrioventricular block and respiratory failure
The Brown University Psychopharmacology Update · 2026-04 · 37 (4) · 2-2
DOI: 10.1002/pu.31426 ↗At a glance
Journal article in The Brown University Psychopharmacology Update, published online on 2026-03-14. Written by Y. W. Francis Lam. 2 references.
Abstract (original language)
The atypical antipsychotic clozapine is highly effective for patients with treatment‐resistant schizophrenia. However, its well‐recognized side‐effect profile, including severe toxicity such as agranulocytosis, limits its use. Significant cardiopulmonary adverse effects also have been associated with clozapine.
Cite
APA
Lam, Y. W. F. (2026). Clozapine‐induced third‐degree atrioventricular block and respiratory failure. The Brown University Psychopharmacology Update, 37(4), 2-2. https://doi.org/10.1002/pu.31426
Vancouver
Lam YWF. Clozapine‐induced third‐degree atrioventricular block and respiratory failure. The Brown University Psychopharmacology Update. 2026;37(4):2-2. doi:10.1002/pu.31426
BibTeX
@article{Lam2026,
author = {Lam, Y. W. Francis},
title = {Clozapine‐induced third‐degree atrioventricular block and respiratory failure},
journal = {The Brown University Psychopharmacology Update},
year = {2026},
volume = {37},
number = {4},
pages = {2--2},
doi = {10.1002/pu.31426}
}
EUVIMED